2018-2023 Global Recombinant Coagulation Factors Market Report (Status and Outlook)

October 2018 | 115 pages | ID: 2849CF7B041EN
LP Information

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

In this report, LP Information studies the present scenario (with the base year being 2017) and the growth prospects of global Recombinant Coagulation Factors market for 2018-2023.

Recombinant coagulation factors are plasma derived counterparts used to treat infection from viruses such as hepatitis C and the human immunodeficiency virus. In addition, recombinant coagulation factors have low risk for transmission of infectious agents.
Over the next five years, LPI(LP Information) projects that Recombinant Coagulation Factors will register a xx% CAGR in terms of revenue, reach US$ xx million by 2023, from US$ xx million in 2017.

This report presents a comprehensive overview, market shares and growth opportunities of Recombinant Coagulation Factors market by product type, application, key companies and key regions.

To calculate the market size, LP Information considers value generated from the sales of the following segments:

Segmentation by product type:

• Recombinant Factor VIII
• Recombinant Factor IX

Segmentation by application:

• Hospitals
• Clinics
• Research Organizations

We can also provide the customized separate regional or country-level reports, for the following regions:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Spain
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report:

• Baxter International Inc.
• Bayer AG
• Biogen Idec
• CSL Ltd.
• Grifols International SA
• Kedrion S.P.A.
• Novo Nordisk A/S
• Octapharma AG
• Pfizer Inc.

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key players and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives

• To study and analyze the global Recombinant Coagulation Factors market size by key regions/countries, product type and application, history data from 2013 to 2017, and forecast to 2023.
• To understand the structure of Recombinant Coagulation Factors market by identifying its various subsegments.
• Focuses on the key global Recombinant Coagulation Factors players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
• To analyze the Recombinant Coagulation Factors with respect to individual growth trends, future prospects, and their contribution to the total market.
• To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
• To project the size of Recombinant Coagulation Factors submarkets, with respect to key regions (along with their respective key countries).
• To analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.
• To strategically profile the key players and comprehensively analyze their growth strategies.

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Recombinant Coagulation Factors Market Size 2013-2023
  2.1.2 Recombinant Coagulation Factors Market Size CAGR by Region
2.2 Recombinant Coagulation Factors Segment by Type
  2.2.1 Recombinant Factor VIII
  2.2.2 Recombinant Factor IX
  2.2.3 Von Willebrand Factor
2.3 Recombinant Coagulation Factors Market Size by Type
  2.3.1 Global Recombinant Coagulation Factors Market Size Market Share by Type (2013-2018)
  2.3.2 Global Recombinant Coagulation Factors Market Size Growth Rate by Type (2013-2018)
2.4 Recombinant Coagulation Factors Segment by Application
  2.4.1 Hospitals
  2.4.2 Clinics
  2.4.3 Research Organizations
2.5 Recombinant Coagulation Factors Market Size by Application
  2.5.1 Global Recombinant Coagulation Factors Market Size Market Share by Application (2013-2018)
  2.5.2 Global Recombinant Coagulation Factors Market Size Growth Rate by Application (2013-2018)

3 GLOBAL RECOMBINANT COAGULATION FACTORS BY PLAYERS

3.1 Global Recombinant Coagulation Factors Market Size Market Share by Players
  3.1.1 Global Recombinant Coagulation Factors Market Size by Players (2016-2018)
  3.1.2 Global Recombinant Coagulation Factors Market Size Market Share by Players (2016-2018)
3.2 Global Recombinant Coagulation Factors Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 RECOMBINANT COAGULATION FACTORS BY REGIONS

4.1 Recombinant Coagulation Factors Market Size by Regions
4.2 Americas Recombinant Coagulation Factors Market Size Growth
4.3 APAC Recombinant Coagulation Factors Market Size Growth
4.4 Europe Recombinant Coagulation Factors Market Size Growth
4.5 Middle East & Africa Recombinant Coagulation Factors Market Size Growth

5 AMERICAS

5.1 Americas Recombinant Coagulation Factors Market Size by Countries
5.2 Americas Recombinant Coagulation Factors Market Size by Type
5.3 Americas Recombinant Coagulation Factors Market Size by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries

6 APAC

6.1 APAC Recombinant Coagulation Factors Market Size by Countries
6.2 APAC Recombinant Coagulation Factors Market Size by Type
6.3 APAC Recombinant Coagulation Factors Market Size by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries

7 EUROPE

7.1 Europe Recombinant Coagulation Factors by Countries
7.2 Europe Recombinant Coagulation Factors Market Size by Type
7.3 Europe Recombinant Coagulation Factors Market Size by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Recombinant Coagulation Factors by Countries
8.2 Middle East & Africa Recombinant Coagulation Factors Market Size by Type
8.3 Middle East & Africa Recombinant Coagulation Factors Market Size by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers and Impact
  9.1.1 Growing Demand from Key Regions
  9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 GLOBAL RECOMBINANT COAGULATION FACTORS MARKET FORECAST

10.1 Global Recombinant Coagulation Factors Market Size Forecast (2018-2023)
10.2 Global Recombinant Coagulation Factors Forecast by Regions
  10.2.1 Global Recombinant Coagulation Factors Forecast by Regions (2018-2023)
  10.2.2 Americas Market Forecast
  10.2.3 APAC Market Forecast
  10.2.4 Europe Market Forecast
  10.2.5 Middle East & Africa Market Forecast
10.3 Americas Forecast by Countries
  10.3.1 United States Market Forecast
  10.3.2 Canada Market Forecast
  10.3.3 Mexico Market Forecast
  10.3.4 Brazil Market Forecast
10.4 APAC Forecast by Countries
  10.4.1 China Market Forecast
  10.4.2 Japan Market Forecast
  10.4.3 Korea Market Forecast
  10.4.4 Southeast Asia Market Forecast
  10.4.5 India Market Forecast
  10.4.6 Australia Market Forecast
10.5 Europe Forecast by Countries
  10.5.1 Germany Market Forecast
  10.5.2 France Market Forecast
  10.5.3 UK Market Forecast
  10.5.4 Italy Market Forecast
  10.5.5 Russia Market Forecast
  10.5.6 Spain Market Forecast
10.6 Middle East & Africa Forecast by Countries
  10.6.1 Egypt Market Forecast
  10.6.2 South Africa Market Forecast
  10.6.3 Israel Market Forecast
  10.6.4 Turkey Market Forecast
  10.6.5 GCC Countries Market Forecast
10.7 Global Recombinant Coagulation Factors Forecast by Type
10.8 Global Recombinant Coagulation Factors Forecast by Application

11 KEY PLAYERS ANALYSIS

11.1 Baxter International Inc.
  11.1.1 Company Details
  11.1.2 Recombinant Coagulation Factors Product Offered
  11.1.3 Baxter International Inc. Recombinant Coagulation Factors Revenue, Gross Margin and Market Share (2016-2018)
  11.1.4 Main Business Overview
  11.1.5 Baxter International Inc. News
11.2 Bayer AG
  11.2.1 Company Details
  11.2.2 Recombinant Coagulation Factors Product Offered
  11.2.3 Bayer AG Recombinant Coagulation Factors Revenue, Gross Margin and Market Share (2016-2018)
  11.2.4 Main Business Overview
  11.2.5 Bayer AG News
11.3 Biogen Idec
  11.3.1 Company Details
  11.3.2 Recombinant Coagulation Factors Product Offered
  11.3.3 Biogen Idec Recombinant Coagulation Factors Revenue, Gross Margin and Market Share (2016-2018)
  11.3.4 Main Business Overview
  11.3.5 Biogen Idec News
11.4 CSL Ltd.
  11.4.1 Company Details
  11.4.2 Recombinant Coagulation Factors Product Offered
  11.4.3 CSL Ltd. Recombinant Coagulation Factors Revenue, Gross Margin and Market Share (2016-2018)
  11.4.4 Main Business Overview
  11.4.5 CSL Ltd. News
11.5 Grifols International SA
  11.5.1 Company Details
  11.5.2 Recombinant Coagulation Factors Product Offered
  11.5.3 Grifols International SA Recombinant Coagulation Factors Revenue, Gross Margin and Market Share (2016-2018)
  11.5.4 Main Business Overview
  11.5.5 Grifols International SA News
11.6 Kedrion S.P.A.
  11.6.1 Company Details
  11.6.2 Recombinant Coagulation Factors Product Offered
  11.6.3 Kedrion S.P.A. Recombinant Coagulation Factors Revenue, Gross Margin and Market Share (2016-2018)
  11.6.4 Main Business Overview
  11.6.5 Kedrion S.P.A. News
11.7 Novo Nordisk A/S
  11.7.1 Company Details
  11.7.2 Recombinant Coagulation Factors Product Offered
  11.7.3 Novo Nordisk A/S Recombinant Coagulation Factors Revenue, Gross Margin and Market Share (2016-2018)
  11.7.4 Main Business Overview
  11.7.5 Novo Nordisk A/S News
11.8 Octapharma AG
  11.8.1 Company Details
  11.8.2 Recombinant Coagulation Factors Product Offered
  11.8.3 Octapharma AG Recombinant Coagulation Factors Revenue, Gross Margin and Market Share (2016-2018)
  11.8.4 Main Business Overview
  11.8.5 Octapharma AG News
11.9 Pfizer Inc.
  11.9.1 Company Details
  11.9.2 Recombinant Coagulation Factors Product Offered
  11.9.3 Pfizer Inc. Recombinant Coagulation Factors Revenue, Gross Margin and Market Share (2016-2018)
  11.9.4 Main Business Overview
  11.9.5 Pfizer Inc. News

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES AND FIGURES

Table Product Specifications of Recombinant Coagulation Factors
Figure Recombinant Coagulation Factors Report Years Considered
Figure Market Research Methodology
Figure Global Recombinant Coagulation Factors Market Size Growth Rate 2013-2023 ($ Millions)
Table Recombinant Coagulation Factors Market Size CAGR by Region 2013-2023 ($ Millions)
Table Major Players of Recombinant Factor VIII
Table Major Players of Recombinant Factor IX
Table Major Players of Von Willebrand Factor
Table Market Size by Type (2013-2018) ($ Millions)
Table Global Recombinant Coagulation Factors Market Size Market Share by Type (2013-2018)
Figure Global Recombinant Coagulation Factors Market Size Market Share by Type (2013-2018)
Figure Global Recombinant Factor VIII Market Size Growth Rate
Figure Global Recombinant Factor IX Market Size Growth Rate
Figure Global Von Willebrand Factor Market Size Growth Rate
Figure Recombinant Coagulation Factors Consumed in Hospitals
Figure Global Recombinant Coagulation Factors Market: Hospitals (2013-2018) ($ Millions)
Figure Global Hospitals YoY Growth ($ Millions)
Figure Recombinant Coagulation Factors Consumed in Clinics
Figure Global Recombinant Coagulation Factors Market: Clinics (2013-2018) ($ Millions)
Figure Global Clinics YoY Growth ($ Millions)
Figure Recombinant Coagulation Factors Consumed in Research Organizations
Figure Global Recombinant Coagulation Factors Market: Research Organizations (2013-2018) ($ Millions)
Figure Global Research Organizations YoY Growth ($ Millions)
Table Global Recombinant Coagulation Factors Market Size by Application (2013-2018) ($ Millions)
Table Global Recombinant Coagulation Factors Market Size Market Share by Application (2013-2018)
Figure Global Recombinant Coagulation Factors Market Size Market Share by Application (2013-2018)
Figure Global Recombinant Coagulation Factors Market Size in Hospitals Growth Rate
Figure Global Recombinant Coagulation Factors Market Size in Clinics Growth Rate
Figure Global Recombinant Coagulation Factors Market Size in Research Organizations Growth Rate
Table Global Recombinant Coagulation Factors Revenue by Players (2016-2018) ($ Millions)
Table Global Recombinant Coagulation Factors Revenue Market Share by Players (2016-2018)
Figure Global Recombinant Coagulation Factors Revenue Market Share by Players in 2017
Table Global Recombinant Coagulation Factors Key Players Head office and Products Offered
Table Recombinant Coagulation Factors Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
Table Global Recombinant Coagulation Factors Market Size by Regions 2013-2018 ($ Millions)
Table Global Recombinant Coagulation Factors Market Size Market Share by Regions 2013-2018
Figure Global Recombinant Coagulation Factors Market Size Market Share by Regions 2013-2018
Figure Americas Recombinant Coagulation Factors Market Size 2013-2018 ($ Millions)
Figure APAC Recombinant Coagulation Factors Market Size 2013-2018 ($ Millions)
Figure Europe Recombinant Coagulation Factors Market Size 2013-2018 ($ Millions)
Figure Middle East & Africa Recombinant Coagulation Factors Market Size 2013-2018 ($ Millions)
Table Americas Recombinant Coagulation Factors Market Size by Countries (2013-2018) ($ Millions)
Table Americas Recombinant Coagulation Factors Market Size Market Share by Countries (2013-2018)
Figure Americas Recombinant Coagulation Factors Market Size Market Share by Countries in 2017
Table Americas Recombinant Coagulation Factors Market Size by Type (2013-2018) ($ Millions)
Table Americas Recombinant Coagulation Factors Market Size Market Share by Type (2013-2018)
Figure Americas Recombinant Coagulation Factors Market Size Market Share by Type in 2017
Table Americas Recombinant Coagulation Factors Market Size by Application (2013-2018) ($ Millions)
Table Americas Recombinant Coagulation Factors Market Size Market Share by Application (2013-2018)
Figure Americas Recombinant Coagulation Factors Market Size Market Share by Application in 2017
Figure United States Recombinant Coagulation Factors Market Size Growth 2013-2018 ($ Millions)
Figure Canada Recombinant Coagulation Factors Market Size Growth 2013-2018 ($ Millions)
Figure Mexico Recombinant Coagulation Factors Market Size Growth 2013-2018 ($ Millions)
Table APAC Recombinant Coagulation Factors Market Size by Countries (2013-2018) ($ Millions)
Table APAC Recombinant Coagulation Factors Market Size Market Share by Countries (2013-2018)
Figure APAC Recombinant Coagulation Factors Market Size Market Share by Countries in 2017
Table APAC Recombinant Coagulation Factors Market Size by Type (2013-2018) ($ Millions)
Table APAC Recombinant Coagulation Factors Market Size Market Share by Type (2013-2018)
Figure APAC Recombinant Coagulation Factors Market Size Market Share by Type in 2017
Table APAC Recombinant Coagulation Factors Market Size by Application (2013-2018) ($ Millions)
Table APAC Recombinant Coagulation Factors Market Size Market Share by Application (2013-2018)
Figure APAC Recombinant Coagulation Factors Market Size Market Share by Application in 2017
Figure China Recombinant Coagulation Factors Market Size Growth 2013-2018 ($ Millions)
Figure Japan Recombinant Coagulation Factors Market Size Growth 2013-2018 ($ Millions)
Figure Korea Recombinant Coagulation Factors Market Size Growth 2013-2018 ($ Millions)
Figure Southeast Asia Recombinant Coagulation Factors Market Size Growth 2013-2018 ($ Millions)
Figure India Recombinant Coagulation Factors Market Size Growth 2013-2018 ($ Millions)
Figure Australia Recombinant Coagulation Factors Market Size Growth 2013-2018 ($ Millions)
Table Europe Recombinant Coagulation Factors Market Size by Countries (2013-2018) ($ Millions)
Table Europe Recombinant Coagulation Factors Market Size Market Share by Countries (2013-2018)
Figure Europe Recombinant Coagulation Factors Market Size Market Share by Countries in 2017
Table Europe Recombinant Coagulation Factors Market Size by Type (2013-2018) ($ Millions)
Table Europe Recombinant Coagulation Factors Market Size Market Share by Type (2013-2018)
Figure Europe Recombinant Coagulation Factors Market Size Market Share by Type in 2017
Table Europe Recombinant Coagulation Factors Market Size by Application (2013-2018) ($ Millions)
Table Europe Recombinant Coagulation Factors Market Size Market Share by Application (2013-2018)
Figure Europe Recombinant Coagulation Factors Market Size Market Share by Application in 2017
Figure Germany Recombinant Coagulation Factors Market Size Growth 2013-2018 ($ Millions)
Figure France Recombinant Coagulation Factors Market Size Growth 2013-2018 ($ Millions)
Figure UK Recombinant Coagulation Factors Market Size Growth 2013-2018 ($ Millions)
Figure Italy Recombinant Coagulation Factors Market Size Growth 2013-2018 ($ Millions)
Figure Russia Recombinant Coagulation Factors Market Size Growth 2013-2018 ($ Millions)
Figure Spain Recombinant Coagulation Factors Market Size Growth 2013-2018 ($ Millions)
Table Middle East & Africa Recombinant Coagulation Factors Market Size by Countries (2013-2018) ($ Millions)
Table Middle East & Africa Recombinant Coagulation Factors Market Size Market Share by Countries (2013-2018)
Figure Middle East & Africa Recombinant Coagulation Factors Market Size Market Share by Countries in 2017
Table Middle East & Africa Recombinant Coagulation Factors Market Size by Type (2013-2018) ($ Millions)
Table Middle East & Africa Recombinant Coagulation Factors Market Size Market Share by Type (2013-2018)
Figure Middle East & Africa Recombinant Coagulation Factors Market Size Market Share by Type in 2017
Table Middle East & Africa Recombinant Coagulation Factors Market Size by Application (2013-2018) ($ Millions)
Table Middle East & Africa Recombinant Coagulation Factors Market Size Market Share by Application (2013-2018)
Figure Middle East & Africa Recombinant Coagulation Factors Market Size Market Share by Application in 2017
Figure Egypt Recombinant Coagulation Factors Market Size Growth 2013-2018 ($ Millions)
Figure South Africa Recombinant Coagulation Factors Market Size Growth 2013-2018 ($ Millions)
Figure Israel Recombinant Coagulation Factors Market Size Growth 2013-2018 ($ Millions)
Figure Turkey Recombinant Coagulation Factors Market Size Growth 2013-2018 ($ Millions)
Figure GCC Countries Recombinant Coagulation Factors Market Size Growth 2013-2018 ($ Millions)
Figure Global Recombinant Coagulation Factors arket Size Forecast (2018-2023) ($ Millions)
Table Global Recombinant Coagulation Factors Market Size Forecast by Regions (2018-2023) ($ Millions)
Table Global Recombinant Coagulation Factors Market Size Market Share Forecast by Regions
Figure Americas Recombinant Coagulation Factors Market Size 2018-2023 ($ Millions)
Figure APAC Recombinant Coagulation Factors Market Size 2018-2023 ($ Millions)
Figure Europe Recombinant Coagulation Factors Market Size 2018-2023 ($ Millions)
Figure Middle East & Africa Recombinant Coagulation Factors Market Size 2018-2023 ($ Millions)
Figure United States Recombinant Coagulation Factors Market Size 2018-2023 ($ Millions)
Figure Canada Recombinant Coagulation Factors Market Size 2018-2023 ($ Millions)
Figure Mexico Recombinant Coagulation Factors Market Size 2018-2023 ($ Millions)
Figure Brazil Recombinant Coagulation Factors Market Size 2018-2023 ($ Millions)
Figure China Recombinant Coagulation Factors Market Size 2018-2023 ($ Millions)
Figure Japan Recombinant Coagulation Factors Market Size 2018-2023 ($ Millions)
Figure Korea Recombinant Coagulation Factors Market Size 2018-2023 ($ Millions)
Figure Southeast Asia Recombinant Coagulation Factors Market Size 2018-2023 ($ Millions)
Figure India Recombinant Coagulation Factors Market Size 2018-2023 ($ Millions)
Figure Australia Recombinant Coagulation Factors Market Size 2018-2023 ($ Millions)
Figure Germany Recombinant Coagulation Factors Market Size 2018-2023 ($ Millions)
Figure France Recombinant Coagulation Factors Market Size 2018-2023 ($ Millions)
Figure UK Recombinant Coagulation Factors Market Size 2018-2023 ($ Millions)
Figure Italy Recombinant Coagulation Factors Market Size 2018-2023 ($ Millions)
Figure Russia Recombinant Coagulation Factors Market Size 2018-2023 ($ Millions)
Figure Spain Recombinant Coagulation Factors Market Size 2018-2023 ($ Millions)
Figure Egypt Recombinant Coagulation Factors Market Size 2018-2023 ($ Millions)
Figure South Africa Recombinant Coagulation Factors Market Size 2018-2023 ($ Millions)
Figure Israel Recombinant Coagulation Factors Market Size 2018-2023 ($ Millions)
Figure Turkey Recombinant Coagulation Factors Market Size 2018-2023 ($ Millions)
Figure GCC Countries Recombinant Coagulation Factors Market Size 2018-2023 ($ Millions)
Table Global Recombinant Coagulation Factors Market Size Forecast by Type (2018-2023) ($ Millions)
Table Global Recombinant Coagulation Factors Market Size Market Share Forecast by Type (2018-2023)
Table Global Recombinant Coagulation Factors Market Size Forecast by Application (2018-2023) ($ Millions)
Table Global Recombinant Coagulation Factors Market Size Market Share Forecast by Application (2018-2023)
Table Baxter International Inc. Basic Information, Head Office, Major Market Areas and Its Competitors
Table Baxter International Inc. Recombinant Coagulation Factors Revenue and Gross Margin (2016-2018)
Figure Baxter International Inc. Recombinant Coagulation Factors Market Share (2016-2018)
Table Bayer AG Basic Information, Head Office, Major Market Areas and Its Competitors
Table Bayer AG Recombinant Coagulation Factors Revenue and Gross Margin (2016-2018)
Figure Bayer AG Recombinant Coagulation Factors Market Share (2016-2018)
Table Biogen Idec Basic Information, Head Office, Major Market Areas and Its Competitors
Table Biogen Idec Recombinant Coagulation Factors Revenue and Gross Margin (2016-2018)
Figure Biogen Idec Recombinant Coagulation Factors Market Share (2016-2018)
Table CSL Ltd. Basic Information, Head Office, Major Market Areas and Its Competitors
Table CSL Ltd. Recombinant Coagulation Factors Revenue and Gross Margin (2016-2018)
Figure CSL Ltd. Recombinant Coagulation Factors Market Share (2016-2018)
Table Grifols International SA Basic Information, Head Office, Major Market Areas and Its Competitors
Table Grifols International SA Recombinant Coagulation Factors Revenue and Gross Margin (2016-2018)
Figure Grifols International SA Recombinant Coagulation Factors Market Share (2016-2018)
Table Kedrion S.P.A. Basic Information, Head Office, Major Market Areas and Its Competitors
Table Kedrion S.P.A. Recombinant Coagulation Factors Revenue and Gross Margin (2016-2018)
Figure Kedrion S.P.A. Recombinant Coagulation Factors Market Share (2016-2018)
Table Novo Nordisk A/S Basic Information, Head Office, Major Market Areas and Its Competitors
Table Novo Nordisk A/S Recombinant Coagulation Factors Revenue and Gross Margin (2016-2018)
Figure Novo Nordisk A/S Recombinant Coagulation Factors Market Share (2016-2018)
Table Octapharma AG Basic Information, Head Office, Major Market Areas and Its Competitors
Table Octapharma AG Recombinant Coagulation Factors Revenue and Gross Margin (2016-2018)
Figure Octapharma AG Recombinant Coagulation Factors Market Share (2016-2018)
Table Pfizer Inc. Basic Information, Head Office, Major Market Areas and Its Competitors
Table Pfizer Inc. Recombinant Coagulation Factors Revenue and Gross Margin (2016-2018)
Figure Pfizer Inc. Recombinant Coagulation Factors Market Share (2016-2018)